Shopping Cart

Shop

Shopping Cart

DCA VantageĀ® HbA1c & A:C Analyzer – Siemens

SKU: 641021

$3,850.75

Quantity
Please login

Share this Product

Description

Features & Benefits

Easy to use and implement

  • Plug and play installation
  • Simple, one-step calibration scan with every new lot
  • Guided user-interface with step-by-step testing instructions
  • Hassle-free maintenance

Improve patient outcomes and operational costs

  • Increase patient satisfaction when testing during office visit1
  • Aid in lowering HbA1c levels over time2,3
  • Reduce costs associated with post-visit testing1
  • Satisfy HbA1c and kidney check HEDIS quality measures

Failsafe measures for audit risk mitigation

  • QC lockout prevents patient testing if QC not tested or fails
  • Prevent unauthorized users from testing and accessing confidential patient information
  • Eliminate transcription errors with bar-code data entry and automatic transmission of results
  • Link patient results to operators and material lot information (audit-ready)
  • Customizable operator-specific system access mode

Results you can trust

  • Robust reagent cartridges designed to minimize pre-analytical errors associated with sample and reagent handling
  • Consistently meet NGSP and IFCC annual certifications for HbA1c
  • Clinically proven to correlate with lab methods4,5

Assays

  • Hemoglobin A1c (HbA1c)
  • Albumin
  • Creatinine
  • Albumin-to-Creatinine (A:C) Ratio Results

Features

  • The DCA Vantage Analyzer is the diabetes system that delivers clinically proven, clinically relevant HbA1c and A:C Ratio results shown to improve patient compliance
  • Only 1uL of whole blood needed for HbA1c testing
  • HbA1c results in 6 minutes
  • Microalbumin testing allows for early detection of kidney disease ā€“ results available in 7 minutes
  • Printed patient records and electronic transmission to LIS or electronic medical record allows for reduced transcription errors
  • Lot-specific calibration card provides automatic calibration with every cartridge
  • Storage Capacity/Memory: 4000 patient and/or control records and up to 1,000 operator IDs
  • Onboard Printer: 54 mm (2 in) width, thermal/label stock
  • CLIA Waived Hgb A1c
  • CLIA Moderate Complexity for Microalbumin and Creatinine

 

 

In-office HbA1c Results Improve Diabetes Decision Making, Patient Compliance, and Outcomes

Clinical studies show that in-office HbA1c results improve decision making,1Ā patient compliance,2Ā and outcomes. ā€œThe immediate feedback of HbA1c results at the time of patient encounters resulted in a significant improvement of glycemic control at 6-month follow-up and persisted for the 12-month study.ā€3

  • Outcomes improve when healthcare providers are able to discuss A1c results with patients in real time.
  • In-office HbA1c testing helps you more efficiently manage your patient. It may also reduce the effort and time needed to sort, send, receive, and collate lab samples and reports.

An in-office HbA1c system should give you highly accurate results.

In addition, look for:

  • Simplified test procedure with no reagent preparation.
  • Simple and flexible specimen collection.
  • National Glycohemoglobin Standardization Program (NGSP) certified and traceable to International Federation of Clinical Chemistry (IFCC) reference materials and test methods.
  • A system that can also report out IFCC units if required.
  • A robust, easily tailored data management system that supports the way your office works.
  • Ability to enter patient and operator ID.
  • Ability to utilize QC reminders and QC lockout.
  • Minimal maintenance.

aĀ National Glycohemoglobin Standardization Program
bĀ Diabetes Control and Complications Trial

  • National Glycohemoglobin Standardization Program (NGSP) certified and traceable to International Federation of Clinical Chemistry (IFCC) reference materials and test methods.
  • Comparable accuracy to lab HbA1c tests.
  • Simplicity: no reagent preparation, 6 minutes to results, and self-prompting screens.
  • Flexible specimen collection: only requires 1 Ī¼L of capillary or venous blood sample.
  • Decision support: immediate results allow convenient treatment plan adjustments. Additional features include A1c trend graphs and early detection/monitoring of kidney disease (with the optional urine microalbumin/creatinine test).
  • Robust, flexible data management: enter patient and operator ID, print or transfer records to EMR/LIS, flash drive, PC, etc. ā€” all through the easy to use touchscreen display. Stores up to 4,000 records.
  • QC reminder and lockout options: allows the user to easily and conveniently validate system and test result accuracy.
  • Excellent track record and low maintenance.

An in-house study was conducted to assess precision for the DCA HbA1c test.

  • A total of 2160 tests were conducted by testing three different levels of clinical samples in duplicate twice per day over 20 days and across three DCA Vantage analyzers using three (3) different lots of DCA HbA1c reagent.

Ā Ā  Assigned Value

% HbA1c Mean Value

mmol/mol HbA1c Mean Value

% CV

SD

5.0%

5.3

34.4

1.76

0.09

6.5%

6.7

49.7

1.73

0.11

8.0%

8.1

65.0

2.02

Ā 0.16

  • These results demonstrate very tight precision with coefficient of variation (CVs) of 2.0% or less.
___________________
1Ā Thaler LM, Ziemer DC, Gallina DL, et al. Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care. 1999;22:1415-1421.
2Ā Miller CD, Barnes CS, Phillips LS, et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care. 2003;26:1158-1163.
3Ā Cagliero E, Levina DV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in Type 1 and insulin-treated Type 2 diabetic patients. Diabetes Care. 1999;22:1785-1789.
4Ā GHX Market Intelligence, market data report. 4Q 2012 report.
5Ā DCA System Hemoglobin A1c Reagent Kit Instructions for Use, Part Number 10698776.

 

 

Other Information

  • Drop-Ship – Additional shipping charges may apply.
  • Returns may require restocking fe

Additional information

Weight 9 lbs
Dimensions 9 × 10 × 11.5 in
Manufacturer

Brand

DCA VantageĀ®

McKesson #

641021

Country of Origin

United Kingdom

Analyzer Type

Benchtop

Application

Diabetes Management Analyzer

CLIA Classification

CLIA Waived (HbA1c)

CLIA Classified

CLIA Waived

Dimensions

9 X 10 X 11-1/2 Inch

For Use With

For Immunoassay Cartridge

Number of Tests

3 Tests

Power Source

100 to 240VAC, 50/60 Hz, 70 VA, 30 Watts

Purchase Program Type

Standard Purchase Agreement

Readout Type

Digital Display / Printer

Sample Capacity

1 ĀµL Whole Blood / 40 ĀµL Urine Sample Volume

Sample Type

Whole Blood / Urine Sample

Test Name

Hemoglobin A1c, Albumin, Microalbumin/Creatinine, Creatinine, Albumin-to-Creatinine (A:C) Ratio

Time to Results

6 Minute HbA1c Results / 7 Minute A:C Ratio Results

UNSPSC Code

41115819

User Interface

Color Touch Screen Display / Bar Code Reader

Weight

9 lbs.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

DCA VantageĀ® HbA1c & A:C Analyzer – Siemens

$3,850.75
Quantity
Please login